Exact Mass: 490.30560879999996
Exact Mass Matches: 490.30560879999996
Found 94 metabolites which its exact mass value is equals to given mass value 490.30560879999996,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
1-(13Z,16Z-docosadienoyl)-glycero-3-phosphate
[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyloxy]-2-hydroxypropoxy]phosphonic acid
1-(13Z,16Z-docosadienoyl)-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-(13Z,16Z-docosadienoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(13Z,16Z-docosadienoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(22:2(13Z,16Z)/0:0)
{3-[(13Z,16Z)-docosa-13,16-dienoyloxy]-2-hydroxypropoxy}phosphonic acid
LysoPA(22:2(13Z,16Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(22:2(13Z,16Z)/0:0), in particular, consists of one chain of docosadienoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
Sapacitabine
N-{1-[3-cyano-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-1,2-dihydropyrimidin-4-yl}hexadecanamide
(2S)-1-O-palmitoleyl-3-O-beta-D-galactopyranosylglycerol|1-O-palmitoleoyl-3-O-beta-D-galactopyranosyl-sn-glycerol
(2S)-1-O-palmitoleyl-3-O-beta-D-galactopyranosylglycerol|1-O-palmitoleoyl-3-O-beta-D-galactopyranosyl-sn-glycerol
BIX-01294
N-(1-benzylpiperidin-4-yl)-6,7-dimethoxy-2-(4-methyl-1,4-diazepan-1-yl)quinazolin-4-amine
C28H38N6O2 (490.30560879999996)
Phe Ile Ile Val
(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-methylpentanamido]-3-methylbutanoic acid
Phe Ile Leu Val
(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-4-methylpentanamido]-3-methylbutanoic acid
Phe Ile Val Ile
(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-methylbutanamido]-3-methylpentanoic acid
Phe Ile Val Leu
(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-methylbutanamido]-4-methylpentanoic acid
Phe Leu Ile Val
(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-methylpentanamido]-3-methylbutanoic acid
Phe Leu Leu Val
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-4-methylpentanamido]-3-methylbutanoic acid
Phe Leu Val Ile
(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-methylbutanamido]-3-methylpentanoic acid
Phe Leu Val Leu
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-methylbutanamido]-4-methylpentanoic acid
Phe Val Ile Ile
(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-methylpentanamido]-3-methylpentanoic acid
Phe Val Ile Leu
(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-methylpentanamido]-4-methylpentanoic acid
Phe Val Leu Ile
(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-4-methylpentanamido]-3-methylpentanoic acid
Phe Val Leu Leu
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-4-methylpentanamido]-4-methylpentanoic acid
Ile Phe Ile Val
(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-methylbutanoic acid
Ile Phe Leu Val
(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-methylbutanoic acid
Ile Phe Val Ile
(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-methylpentanoic acid
Ile Phe Val Leu
(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-methylbutanamido]-4-methylpentanoic acid
Ile Ile Phe Val
(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-methylbutanoic acid
Ile Ile Val Phe
(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-methylbutanamido]-3-phenylpropanoic acid
Ile Leu Phe Val
(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-methylbutanoic acid
Ile Leu Val Phe
(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-methylbutanamido]-3-phenylpropanoic acid
Ile Val Phe Ile
(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-methylpentanoic acid
Ile Val Phe Leu
(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-phenylpropanamido]-4-methylpentanoic acid
Ile Val Ile Phe
(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-methylpentanamido]-3-phenylpropanoic acid
Ile Val Leu Phe
(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-4-methylpentanamido]-3-phenylpropanoic acid
Leu Phe Ile Val
(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-methylbutanoic acid
Leu Phe Leu Val
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-methylbutanoic acid
Leu Phe Val Ile
(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-methylpentanoic acid
Leu Phe Val Leu
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-methylbutanamido]-4-methylpentanoic acid
Leu Ile Phe Val
(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-methylbutanoic acid
Leu Ile Val Phe
(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-methylbutanamido]-3-phenylpropanoic acid
Leu Leu Phe Val
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-methylbutanoic acid
Leu Leu Val Phe
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-methylbutanamido]-3-phenylpropanoic acid
Leu Val Phe Ile
(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-methylpentanoic acid
Leu Val Phe Leu
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-phenylpropanamido]-4-methylpentanoic acid
Leu Val Ile Phe
(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-methylpentanamido]-3-phenylpropanoic acid
Leu Val Leu Phe
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-4-methylpentanamido]-3-phenylpropanoic acid
Val Phe Ile Ile
(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-methylpentanoic acid
Val Phe Ile Leu
(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-methylpentanamido]-4-methylpentanoic acid
Val Phe Leu Ile
(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-methylpentanoic acid
Val Phe Leu Leu
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-4-methylpentanamido]-4-methylpentanoic acid
Val Ile Phe Ile
(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-methylpentanoic acid
Val Ile Phe Leu
(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-phenylpropanamido]-4-methylpentanoic acid
Val Ile Ile Phe
(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-methylpentanamido]-3-phenylpropanoic acid
Val Ile Leu Phe
(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-4-methylpentanamido]-3-phenylpropanoic acid
Val Leu Phe Ile
(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-methylpentanoic acid
Val Leu Phe Leu
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-phenylpropanamido]-4-methylpentanoic acid
Val Leu Ile Phe
(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-methylpentanamido]-3-phenylpropanoic acid
Val Leu Leu Phe
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-4-methylpentanamido]-3-phenylpropanoic acid
BIX01294
2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]-4-quinazolinamine, trihydrochloride, hydrate
C28H38N6O2 (490.30560879999996)
3-O-alpha-L-rhamnopyranosyl-3-hydroxynonanoyl-3-hydroxydecanoic acid
3-O-alpha-L-rhamnopyranosyl-3-hydroxynonanoyl-3-hydroxydecanoic acid
Sapacitabine
Sapacitabine
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D000970 - Antineoplastic Agents Sapacitabine is an orally available nucleoside analog proagent that is structurally related to cytarabine.